Suppression of activities of carbohydrate-metabolizing enzymes in adipose tissue of obese humans by clofibrate.
D000273:Adipose Tissue / Q000187:drug effects / Q000201:enzymology* / Q000473:pathology; D000328:Adult; D001706:Biopsy; D050260:Carbohydrate Metabolism; D002994:Clofibrate / Q000494:pharmacology*; D006597:Fructose-Bisphosphatase / Q000378:metabolism; D005634:Fructose-Bisphosphate Aldolase / Q000378:metabolism; D005947:Glucose / Q000378:metabolism; D006801:Humans; D008297:Male; D009765:Obesity / Q000201:enzymology*; D010732:Phosphofructokinase-1 / Q000378:metabolism; D011770:Pyruvate Kinase / Q000378:metabolism
D010732:Phosphofructokinase-1; D011770:Pyruvate Kinase; D006597:Fructose-Bisphosphatase; D005634:Fructose-Bisphosphate Aldolase; D002994:Clofibrate; D005947:Glucose